mAbs herapeutics, Inc. Company Presentation January 2022 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2021 Earnings Conference Call November 5, 2021 9:00 AM ET Company Participants Thomas Gad - Founder, Chairman and President Claus Moller - Chief Executive Officer Bo Kruse - Chief Financial Officer Conference Call Participants Alec Stranahan - Bank of America Joseph Thome - Cowen Tessa Romero - JPMorgan Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to he ...

mAbs herapeutics, Inc. Company Presentation September 2021 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans a ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q2 2021 Earnings Conference Call August 6, 2021 9:00 AM ET Company Participants Thomas Gad - Founder, Chairman & President Claus Moller - Chief Executive Officer Bo Kruse - Chief Financial Officer Conference Call Participants Alec Stranahan - Bank of America David Lebowitz - Morgan Stanley Robert Burns - HC Wainwright Joseph Thome - Cowen & Company Etzer Darout - Guggenheim David Nierengarten - Wedbush Securities Tessa Romero - JPMorgan Arlinda Lee - Canaccord Operato ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2021 Earnings Conference Call May 7, 2021 9:00 AM ET Company Participants Thomas Gad - Founder, Chairman & President Claus Moller - Chief Executive Officer Bo Kruse - Chief Financial Officer Conference Call Participants David Lebowitz - Morgan Stanley Alec Stranahan - Bank of America Etzer Darout - Guggenheim Joe Thome - Cowen Robert Burns - HC Wainwright Peter Lawson - Barclays Tessa Romero – JPMorgan Operator Good day and welcome to the Y-mAbs Therapeutics Incorp ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2020 Earnings Conference Call February 26, 2021 9:00 AM ET Company Participants Thomas Gad – Chairman Claus Moller – Chief Executive Officer Bo Kruse – Chief Financial Officer Conference Call Participants Alec Stranahan – Bank of America Robert Burns – H.C. Wainwright Paul Jeng – Guggenheim David Lebovitz – Morgan Stanley Tessa Romero – J.P. Morgan Peter Lawson – Barclays Sebastiaan van der Schoot – Kempen & Company Operator Greetings, and welcome to Y-mAbs Fourth ...

mAbs herapeutics, Inc. Company Presentation February 2021 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans an ...

mAbs herapeutics, Inc. Company Presentation January 2021 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2020 Earnings Conference Call November 6, 2020 9:00 AM ET Company Participants Thomas Gad - Chairman of the Board, President, Founder, Head of Business Development & Strategy Claus Moller - Chief Executive Officer Bo Kruse - Chief Financial Officer, Treasurer & Secretary Conference Call Participants Robert Burns - H.C. Wainwright David Lebowitz - Morgan Stanley Etzer Darout - Guggenheim Alec Stranahan - Bank of America Anupam Rama - JPMorgan Peter Lawson - Barclays ...

mAbs herapeutics, Inc. Company Presentation September 2020 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans a ...